Skip to main content
Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
75.36
+1.32 (1.78%)
At close: Mar 9, 2026, 4:00 PM EDT
75.36
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:47 PM EDT

Ionis Pharmaceuticals Revenue

In the year 2025, Ionis Pharmaceuticals had annual revenue of $943.71M with 33.83% growth. Ionis Pharmaceuticals had revenue of $203.33M in the quarter ending December 31, 2025, a decrease of -10.26%.

Revenue (ttm)
$943.71M
Revenue Growth
+33.83%
P/S Ratio
13.19
Revenue / Employee
$673,118
Employees
1,402
Market Cap
12.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025943.71M238.57M33.83%
Dec 31, 2024705.14M-82.51M-10.48%
Dec 31, 2023787.65M200.28M34.10%
Dec 31, 2022587.37M-223.09M-27.53%
Dec 31, 2021810.46M81.19M11.13%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jazz Pharmaceuticals 4.27B
Genmab 3.72B
BioMarin Pharmaceutical 3.22B
Exelixis 2.32B
Madrigal Pharmaceuticals 958.40M
Ascendis Pharma 845.52M
BridgeBio Pharma 502.08M
ImmunityBio 113.29M
Revenue Rankings

IONS News

More News